Showing results (1-10 of 311) with videos related to
Sort By:
Pageof 32
Viszeralmedizin|October 16, 2015
How Should Cancer Surveillance in Primary Sclerosing Cholangitis Be Performed?Hanno Ehlken, Christoph SchrammDigestive Diseases (Basel, Switzerland)|June 26, 2013
Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnosticsHanno Ehlken, Christoph SchrammCurrent Opinion in Gastroenterology|February 2, 2017
Risk of cholangiocarcinoma in patients with primary sclerosing cholangitis: diagnosis and surveillanceHanno Ehlken, Roman Zenouzi, Christoph SchrammDeutsche Medizinische Wochenschrift (1946)|March 3, 2020
[Diagnostics and Treatment of indeterminate Biliary Stenoses]Jenny Krause, Hanno Ehlken, Christoph SchrammClinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 8, 2019
Rate of Spleen Length Progression Is a Marker of Outcome in Patients With Primary Sclerosing CholangitisFranziska Jung, Nora Cazzagon, Eik Vettorazzi, et al.International Journal of Cancer|November 26, 2003
Humoral immune response against melanoma antigens induced by vaccination with cytokine gene-modified autologous tumor cellsHanno Ehlken, Dirk Schadendorf, Stefan EichmüllerHepatology (Baltimore, Md.)|March 19, 2016
Opposing role of tumor necrosis factor receptor 1 signaling in T cell-mediated hepatitis and bacterial infection in miceRaluca Wroblewski, Marietta Armaka, Vangelis Kondylis, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 18, 2022
Bile Duct Colonization With Enterococcus sp. Associates With Disease Progression in Primary Sclerosing CholangitisEhud Zigmond, Britta Franziska Zecher, Anna-Lena Bartels, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 28, 2017
Efficacy and Limitations of Budesonide as a Second-Line Treatment for Patients With Autoimmune HepatitisMoritz Peiseler, Tina Liebscher, Marcial Sebode, et al.Journal of Hepatology|December 3, 2014
Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitisJohannes Hartl, Hanno Ehlken, Christina Weiler-Normann, et al.Pageof 32